Insiders EQL Pharma AB

Equities

EQL

SE0005497732

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-07 EDT			5-day change	1st Jan Change
43.8 ^SEK	-0.23%		+0.92%	+31.14%

04-22	EQL Pharma AB Announces Mellozzan Launched in Germany and Austria	CI
02-13	EQL Pharma AB Provides Sales Guidance for the Year 2023/24	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EQL Pharma Recruits Carl Lindgren as Chief Business Development Officer	23-03-13	CI
Nomination committee for the 2023 Annual General Meeting	23-02-21	AQ
Correction MAR label: Axel Schörling has, in accordance with the plan, started as new CEO in EQL Pharma AB and Martin Kristoffersson is appointed new COO.	22-08-18	AQ
EQL Pharma Appoints New CEO, COO	22-08-18	MT
Axel Schörling has, in accordance with the plan, started as new CEO in EQL Pharma AB and Martin Kristoffersson is appointed new COO.	22-08-18	AQ
EQL Pharma AB Announces Executive Changes	22-08-18	CI
Eql Pharma AB Announces Executive Changes	22-08-18	CI
EQL Pharma AB Announces Executive Changes	22-08-17	CI
EQL Pharma : Instruction for the Nomination Committee	22-07-08	PU
EQL Pharma Appoints New CFO	21-12-16	MT
EQL Pharma AB Appoints Anna Jönsson as Permanent Chief Financial Officer	21-12-16	CI
EQL Pharma CEO To Step Down In 2022, Successor Named	21-11-11	MT
EQL Pharma AB Announces CEO Changes	21-11-10	CI
EQL Pharma AB Announces Board Changes	21-08-17	CI
EQL Pharma AB Convenes Nomination Committee	21-02-12	CI
EQL Pharma AB Elects Anders Månsson to Board of Directors	18-08-22	CI
EQL Pharma Appoints Axel Schörling as Chief Operating Officer	17-12-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW